Review




Structured Review

10X Genomics rt buffer b
Rt Buffer B, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/buffer+b/pm42260119-394-14-17
Average 86 stars, based on 1 article reviews
rt buffer b - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

Incubation:

Article Title: UDA-seq: universal droplet microfluidics-based combinatorial indexing for massive-scale multimodal single-cell sequencing.
Article Snippet: The supernatant was removed without disrupting the nuclei pellet, then the pellet was resuspended in chilled PBS-RNase inhibitor (1× PBS supplemented with 1 U μl−1 RNase inhibitor (3335399001; Sigma)). .. A certain number of fixed nuclei (5 μl) were resuspended in transposition mix (7 μl ATAC buffer B, 3 μl ATAC enzyme B, PN-1000283; 10x Genomics) and incubated at 37 °C for 60 min. .. After chromatin tagmentation, nuclei were partitioned and barcoded using the Chromium Controller (10x Genomics) and the Chromium Next GEM Single Cell Multiome ATAC + Gene Expression (PN-1000283; 10x Genomics) according to the manufacturer’s recommended protocol.

Article Title: Single-nucleus epigenomic profiling of the adult human central nervous system unveils epigenetic memory of developmental programs
Article Snippet: Single-cell indexing was performed according to Chromium Next GEM Single Cell ATAC Library and Gel Bead Kit (v1.1; 10x Genomics) instructions. .. Nuclei of 8 μl were added to 7 μl ATAC buffer B (10x Genomics) and loaded onto the Chromium Chip H. GEM incubation and post-GEM incubation clean-up were performed according to Chromium Next GEM Single Cell ATAC Reagent Kits (v1.1) instructions (step 2.0–3.2). ..

Article Title: Single-nucleus epigenomic profiling of the adult human central nervous system unveils epigenetic memory of developmental programs.
Article Snippet: A total of 2 μl were used for counting (1:5 diluted in trypan blue). nanoCUT&Tag library preparation and sequencing Single-cell indexing was performed according to Chromium Next GEM Single Cell ATAC Library and Gel Bead Kit (v1.1; 10x Genomics) instructions. .. Nuclei of 8 μl were added to 7 μl ATAC buffer B (10x Genomics) and loaded onto the Chromium Chip H. GEM incubation and post-GEM incubation clean-up were performed according to Chromium Next GEM Single Cell ATAC Reagent Kits (v1.1) instructions (step 2.0–3.2). ..

Virus:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

Single Cell:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

Article Title: Generation of antigen-specific paired chain antibodies using large language models
Article Snippet: .. B cell Single Cell V(D)J solution , 10X Genomics , N/A. .. ExpiFectamine TM 293 Transfection Kit , Thermo Fisher , Cat #A14526.

Article Title: Single-nucleus epigenomic profiling of the adult human central nervous system unveils epigenetic memory of developmental programs
Article Snippet: Single-cell indexing was performed according to Chromium Next GEM Single Cell ATAC Library and Gel Bead Kit (v1.1; 10x Genomics) instructions. .. Nuclei of 8 μl were added to 7 μl ATAC buffer B (10x Genomics) and loaded onto the Chromium Chip H. GEM incubation and post-GEM incubation clean-up were performed according to Chromium Next GEM Single Cell ATAC Reagent Kits (v1.1) instructions (step 2.0–3.2). ..

Article Title: Single-nucleus epigenomic profiling of the adult human central nervous system unveils epigenetic memory of developmental programs.
Article Snippet: A total of 2 μl were used for counting (1:5 diluted in trypan blue). nanoCUT&Tag library preparation and sequencing Single-cell indexing was performed according to Chromium Next GEM Single Cell ATAC Library and Gel Bead Kit (v1.1; 10x Genomics) instructions. .. Nuclei of 8 μl were added to 7 μl ATAC buffer B (10x Genomics) and loaded onto the Chromium Chip H. GEM incubation and post-GEM incubation clean-up were performed according to Chromium Next GEM Single Cell ATAC Reagent Kits (v1.1) instructions (step 2.0–3.2). ..

Transfection:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

Conjugation Assay:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

Plasmid Preparation:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

DNA Extraction:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

Chromatography:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

Next-Generation Sequencing:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

Cryo-EM Sample Prep:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

Cell Culture:

Article Title: Generation of antigen-specific paired-chain antibodies using large language models.
Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Goat anti-human IgG-HRP Thermo Fisher Cat # A18817; RRID: AB_2535594 Mouse anti-RSV F (MCA490) Bio-Rad Cat# MCA490; RRID:AB_2231368 S309 PMID: 32422645 PBD: 6WS6 VRC01 BEI Resources ARP-12033; RRID: AB_2491019 CR9114 PMID: 22878502 GenBank: JX213639, JX213640 MEDI8852 PMID: 27453466 RRID: AB_3111586 5-1 Abu-Shmais et al. 35 N/A APC-Cy7 Mouse Anti-Human CD14 BD Cat# 561709; RRID: AB_10893806 FITC Anti-Human CD3 (OKT3) Tonbo Biosciences Cat# 35–0037; RRID: AB_2621662 BV711 Mouse Anti-Human CD19 BD Cat# 563036; RRID: AB_2737968 PE-Cy5 Mouse Anti-Human IgG BD Cat# 551497; RRID: AB_394220 Bacterial and virus strains RSV A2 strain BEI Resources NR-52018 SARS-CoV-2 index pseudovirus Daniel Sheward N/A SARS-CoV-1 pseudovirus Daniel Sheward N/A SARS-CoV-2 Delta pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 Gamma pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2.75.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 B.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BJ.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.2 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BA.5 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 BQ.1.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 JN.1 pseudotyped lentivirus Daniel Sheward N/A SARS-CoV-2 XBB.1.5 pseudotyped lentivirus Daniel Sheward N/A H5N1 A/Texas/37/2024 Rebecca A. Gillespie N/A H5N1 A/Vietnam/1203/2004 Rebecca A. Gillespie N/A H1N1 A/Michigan/45/2015 Rebecca A. Gillespie N/A H5N1 A/Cambodia/2023 Rebecca A. Gillespie N/A H5N2 A/Mexico/2024 Rebecca A. Gillespie N/A H2N2 A/Singapore/1/57 Rebecca A. Gillespie N/A Biological samples Human PBMCs (healthy) StemCell Technologies Cat# 70025 Human PBMCs (HIV-1+) Mark Connors N/A Human PBMCs (COVID-19 convalescent) Helen Chu N/A Human PBMCs (Influenza vaccinated) Ted Ross N/A Chemicals, peptides, and recombinant proteins Polyethyleniminine Linear MW 25000 Polysciences Cat#23966-1 1-Step Ultra TMB-ELISA Substrate Solution Thermo Fisher Cat#34029 Pluronic Acid F-68 Fisher Cat# 24040-032 Bovine serum albumin (BSA) Sigma-Aldrich A1470 Ghost dye red 780 Tonbo biosciences Cat#13-0865 4 mM L-glutamine Fisher Cat# 25030-081 Protein A resin GenScript Cat#L00210 (Continued on next page) ll OPEN ACCESS Cell 188, 1–16.e1–e8, December 11, 2025 e1 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. REAGENT or RESOURCE SOURCE IDENTIFIER Lyra-CoV Spike Wall et al. 31 N/A SARS-CoV-2 Index RBD Sino Biological Cat# 40592-VNAH SARS-CoV-2 HexaPro Index Spike PMID: 32703906 N/A SARS-CoV-1 S Jason McLellan N/A HCoV-OC43 S Jason McLellan N/A HCoV-HKU1-S-2P PMID: 28807998 N/A RSV A2 DS-Cav1 prefusion F Jason McLellan N/A RSV B9320 DS-Cav1 prefusion F Jason McLellan N/A RSV post-fusion Jason McLellan N/A hMPV F A1(NL/1/00) Jason McLellan N/A hMPV F B2(TN99-419) Jason McLellan N/A hMPV A postfusion F Jason McLellan N/A Parainfluenza virus type 3 prefusion stabilized F ectodomain PMID: 30420505 PDB: 6MJZ H5/TX/24 hemagglutinin Genscript GenBank PP577943.1 H3 HK68 Masaru Kanekiyo N/A H3 Perth19 Masaru Kanekiyo N/A H1 MI15 Masaru Kanekiyo N/A H1 NC99 Masaru Kanekiyo N/A B2 SG57 Masaru Kanekiyo N/A HA B/Wash/19 Masaru Kanekiyo N/A H5 VN04 Masaru Kanekiyo N/A H5 IN05 Masaru Kanekiyo N/A H7 Anh13 Masaru Kanekiyo N/A H5 HK09 Masaru Kanekiyo N/A H10 JD13 Masaru Kanekiyo N/A HIV-1 gp140 SOSIP BG505 Ivelin Georgiev N/A HIV-1 ZM197 env Ivelin Georgiev N/A HIV-1 B4.1 env Ivelin Georgiev N/A Norovirus CHDC P domain Grant Hansman N/A Norovirus SYD_2012 P domain Grant Hansman N/A Norovirus GII.17 P domain Grant Hansman N/A Critical commercial assays B cell Single Cell V(D)J solution 10X Genomics N/A ExpiFectamineTM 293 Transfection Kit Thermo Fisher Cat #A14526 EZ-link Sulfo-NHS-Biotin No-Weigh Thermo Fisher Cat #A39258 Solulink protein-oligonucleotide conjugation kit TriLink Biotechnologies Cat#S-9011 Plasmid Kits for Plasmid DNA Extraction QIAGEN Cat#12165 StrepTrap XT prepacked chromatography column Cytiva Cat#29401322 Deposited data Raw next-generation sequencing data This paper SRA: PRJNA1321287 Cryo-EM structure RSV-3301 and RSV-2245 fabs bound to RSV-A F This paper PDB: 9MKN, EMDB: EMD-48331 Experimental models: Cell lines Human: Expi293F cells Thermo Fisher Cat#A14527 HEK293T ATCC CRL-3216 Vero cells ATCC CCL-81 E. coli DH5α Cell Culture Core N/A (Continued on next page) ll OPEN ACCESS e2 Cell 188, 1–16.e1–e8, December 11, 2025 Please cite this article in press as: Wasdin et al., Generation of antigen-specific paired-chain antibodies using large language models, Cell (2025), https://doi.org/10.1016/j.cell.2025.10.006 Article .. Cell lines used in this study include Expi293F (Thermo Fisher), HEK293T (ATCC), and Vero cells (ATCC).

other:

Article Title: Myeloid lineage C3 induces reactive gliosis and neuronal stress during CNS inflammation
Article Snippet: For samples WT-1, KO-1, and KO-2 we transferred 5 μL of nuclei (~1543, 5901, and 3106 nuclei respectively) into 10 μL transposition mix (7 μL ATAC Buffer B (10X Genomics, cat 2000193)), 3 μL ATAC Enzyme B (10X genomics, cat 2000272).

Article Title: A Cross-Species Atlas of the Dorsal Vagal Complex Reveals Neural Mediators of Cagrilintide’s Effects on Energy Balance
Article Snippet: The DAPI positive nuclei were sorted into a 2 ml Protein LoBind tube with 18.8 μl RT Buffer B (10X Genomics, 2000165) for library preparation.



Similar Products

94
Cell Signaling Technology Inc x buffer a
X Buffer A, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/buffer+b/SimpleChIP+Enzymatic+Cell+Lysis+Buffers+A+%26amp%2C+B/pm42858641-114-15-21
Average 94 stars, based on 1 article reviews
x buffer a - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
ADS Biotec buffer b
Buffer B, supplied by ADS Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/buffer+b/Hexylammonium+Acetate+Buffer+B+-+0%2E1+M+HAA+in+50%25+Acetonitrile/pmc13542726-73-22-30
Average 94 stars, based on 1 article reviews
buffer b - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
10X Genomics rt buffer b
Rt Buffer B, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/buffer+b/pm42260119-394-14-17
Average 86 stars, based on 1 article reviews
rt buffer b - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Fisher Scientific buffer b
Buffer B, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/buffer+b/buffer+lysis/bio_rxiv__64898__2026__05__13__724352-122-9-16
Average 86 stars, based on 1 article reviews
buffer b - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Zytomed Inc tris wash buffer b
Tris Wash Buffer B, supplied by Zytomed Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/buffer+b/buffer+tris+wash/pm42122993-104-10-15
Average 86 stars, based on 1 article reviews
tris wash buffer b - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

99
Thermo Fisher ramos b cells
Ramos B Cells, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/buffer+b/RIPA+buffer/pm41998187-308-6-56
Average 99 stars, based on 1 article reviews
ramos b cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
Bio-Rad buffer b trf2 rap1
<t>TRF2–RAP1</t> <t>interaction</t> enhances TRF2’s binding to telomere R-loops. ( A, B ) TRF2 binds 32 P-TERRA and telomere R-loops. His-tagged TRF2 protein (0–80 nM) was incubated with 5 nM radiolabeled TERRA (A) or telomere R-loops (B). The mobility shifts of the TRF2–RNA complex were analyzed by 10% native polyacrylamide gel electrophoresis. ( C ) Quantification of the binding data in panels (A, B). The error bars represent mean values ± SD of data from three independent experiments. ( D ) TRF2–RAP1 interaction enhances TRF2’s binding to telomere R-loops. Purified WT TRF2, mutants TRF2 ΔB , TRF2 L288R , TRF2 ΔB,L288R , and WT RAP1 alone or in the indicated combinations were tested for telomere R-loop binding. The mobility shift of the TRF2–RNA complexes was analyzed by 10% polyacrylamide gels. ( E, F ) Quantification of the R-loop binding data in panel (D). Error bars represent mean values ± SD of data from three independent experiments. ( G ) TRF2 (50, 100, 150, 200, and 250 nM) without or with RAP1 (100 nM) was incubated with telomere dsDNA and R-loops (10 nM each) to determine relative binding affinities. The ability of TRF2 or TRF2–RAP1 to bind to these nucleic acid substrates was analyzed by 10% polyacrylamide gels. ( H, I ) The R-loop and dsDNA binding data in panel (G) were quantified and plotted. Error bars represent mean values ± SD of data from three independent experiments.
Buffer B Trf2 Rap1, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/buffer+b/Micro+Bio-Spin+6/pmc13036488-88-19-16
Average 96 stars, based on 1 article reviews
buffer b trf2 rap1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


TRF2–RAP1 interaction enhances TRF2’s binding to telomere R-loops. ( A, B ) TRF2 binds 32 P-TERRA and telomere R-loops. His-tagged TRF2 protein (0–80 nM) was incubated with 5 nM radiolabeled TERRA (A) or telomere R-loops (B). The mobility shifts of the TRF2–RNA complex were analyzed by 10% native polyacrylamide gel electrophoresis. ( C ) Quantification of the binding data in panels (A, B). The error bars represent mean values ± SD of data from three independent experiments. ( D ) TRF2–RAP1 interaction enhances TRF2’s binding to telomere R-loops. Purified WT TRF2, mutants TRF2 ΔB , TRF2 L288R , TRF2 ΔB,L288R , and WT RAP1 alone or in the indicated combinations were tested for telomere R-loop binding. The mobility shift of the TRF2–RNA complexes was analyzed by 10% polyacrylamide gels. ( E, F ) Quantification of the R-loop binding data in panel (D). Error bars represent mean values ± SD of data from three independent experiments. ( G ) TRF2 (50, 100, 150, 200, and 250 nM) without or with RAP1 (100 nM) was incubated with telomere dsDNA and R-loops (10 nM each) to determine relative binding affinities. The ability of TRF2 or TRF2–RAP1 to bind to these nucleic acid substrates was analyzed by 10% polyacrylamide gels. ( H, I ) The R-loop and dsDNA binding data in panel (G) were quantified and plotted. Error bars represent mean values ± SD of data from three independent experiments.

Journal: Nucleic Acids Research

Article Title: TRF2–RAP1 inhibits homology-directed repair of telomeres by promoting BLM-mediated removal of telomere R-loops

doi: 10.1093/nar/gkag272

Figure Lengend Snippet: TRF2–RAP1 interaction enhances TRF2’s binding to telomere R-loops. ( A, B ) TRF2 binds 32 P-TERRA and telomere R-loops. His-tagged TRF2 protein (0–80 nM) was incubated with 5 nM radiolabeled TERRA (A) or telomere R-loops (B). The mobility shifts of the TRF2–RNA complex were analyzed by 10% native polyacrylamide gel electrophoresis. ( C ) Quantification of the binding data in panels (A, B). The error bars represent mean values ± SD of data from three independent experiments. ( D ) TRF2–RAP1 interaction enhances TRF2’s binding to telomere R-loops. Purified WT TRF2, mutants TRF2 ΔB , TRF2 L288R , TRF2 ΔB,L288R , and WT RAP1 alone or in the indicated combinations were tested for telomere R-loop binding. The mobility shift of the TRF2–RNA complexes was analyzed by 10% polyacrylamide gels. ( E, F ) Quantification of the R-loop binding data in panel (D). Error bars represent mean values ± SD of data from three independent experiments. ( G ) TRF2 (50, 100, 150, 200, and 250 nM) without or with RAP1 (100 nM) was incubated with telomere dsDNA and R-loops (10 nM each) to determine relative binding affinities. The ability of TRF2 or TRF2–RAP1 to bind to these nucleic acid substrates was analyzed by 10% polyacrylamide gels. ( H, I ) The R-loop and dsDNA binding data in panel (G) were quantified and plotted. Error bars represent mean values ± SD of data from three independent experiments.

Article Snippet: The deproteinized reaction mixtures by SDS and proteinase K were passed through Micro Bio-Spin 6 Column (Bio-Rad), equilibrated with buffer B. TRF2–RAP1 (50 nM) was pre-incubated with the D/R-loop substrate (2.5 nM) on ice for 10 min. Then BLM (20–80 nM) was added and incubated at 37°C for 20 min.

Techniques: Binding Assay, Incubation, Polyacrylamide Gel Electrophoresis, Purification, Mobility Shift

TRF2–RAP1 promotes BLM-mediated unwinding of telomere R-loops. ( A ) (Top) Schematic of the oligo-based telomere R-loop unwinding assay. Telomere R-loop substrates were generated by hybridizing 32 P-labeled TERRA and two telomere DNA fragments (TDR2 and TDR3). TRF2 and/or RAP1 were pre-incubated with the R-loops and then BLM was added to the reaction, and the complex was resolved by 10% native polyacrylamide gel electrophoresis to monitor for R-loop unwinding. Displacement of the invading radiolabeled TERRA from R-loops indicates that R-loop unwinding. (Bottom) The TRF2–RAP1 complex promotes BLM-mediated unwinding of telomere R-loops. The effects of TRF2 alone (40, 80 nM) or in combination with RAP1 (20, 40, 80 nM) on the ability of BLM (20 nM) to unwind telomere R-loops were examined. 32 P-labeled TERRA and R-loops were resolved by native-PAGE and shown in lanes 1 and 2. ( B ) Quantification of BLM-mediated R-loop unwinding reactions in panel (A). The percentages of unwound R-loops are shown as mean values ± SD from three independent experiments. Statistical evaluation was performed by ANOVA test. ns: non-significant ( P = .9485); **** P < .0001. ( C ) The TRF2 basic domain is required for efficient unwinding of telomere R-loops. The effect of WT TRF2, TRF2 ΔB , TRF2 ΔB,L288R , and RAP1 to enhance BLM-mediated telomere R-loop unwinding was examined. The sizes of 32 P-labeled TERRA and R-loops were resolved by native-PAGE, as shown in lanes 1 and 2. ( D ) Quantification of BLM-mediated R-loop unwinding reactions in panel (C). The percentages of unwound R-loops are shown as mean values ± SD from three independent experiments. Statistical evaluation was performed by ANOVA test. **** P < .0001. ( E ) The TRF2–BLM interaction enhances telomere R-loop unwinding. The effect of TRF2–RAP1 on the ability of WT and mutant BLM (3A or P690L) to unwind telomere R-loops was tested as in Fig. . 32 P-labeled TERRA and R-loops were loaded as size markers (lanes 1 and 2) and resolved by native-PAGE. ( F ) Quantification of the percentages of unwound R-loops in panel (E) as mean ± SD from three independent experiments. Statistical evaluation was performed by ANOVA test. ns: non-significant ( P = .98); **** P < .0001.

Journal: Nucleic Acids Research

Article Title: TRF2–RAP1 inhibits homology-directed repair of telomeres by promoting BLM-mediated removal of telomere R-loops

doi: 10.1093/nar/gkag272

Figure Lengend Snippet: TRF2–RAP1 promotes BLM-mediated unwinding of telomere R-loops. ( A ) (Top) Schematic of the oligo-based telomere R-loop unwinding assay. Telomere R-loop substrates were generated by hybridizing 32 P-labeled TERRA and two telomere DNA fragments (TDR2 and TDR3). TRF2 and/or RAP1 were pre-incubated with the R-loops and then BLM was added to the reaction, and the complex was resolved by 10% native polyacrylamide gel electrophoresis to monitor for R-loop unwinding. Displacement of the invading radiolabeled TERRA from R-loops indicates that R-loop unwinding. (Bottom) The TRF2–RAP1 complex promotes BLM-mediated unwinding of telomere R-loops. The effects of TRF2 alone (40, 80 nM) or in combination with RAP1 (20, 40, 80 nM) on the ability of BLM (20 nM) to unwind telomere R-loops were examined. 32 P-labeled TERRA and R-loops were resolved by native-PAGE and shown in lanes 1 and 2. ( B ) Quantification of BLM-mediated R-loop unwinding reactions in panel (A). The percentages of unwound R-loops are shown as mean values ± SD from three independent experiments. Statistical evaluation was performed by ANOVA test. ns: non-significant ( P = .9485); **** P < .0001. ( C ) The TRF2 basic domain is required for efficient unwinding of telomere R-loops. The effect of WT TRF2, TRF2 ΔB , TRF2 ΔB,L288R , and RAP1 to enhance BLM-mediated telomere R-loop unwinding was examined. The sizes of 32 P-labeled TERRA and R-loops were resolved by native-PAGE, as shown in lanes 1 and 2. ( D ) Quantification of BLM-mediated R-loop unwinding reactions in panel (C). The percentages of unwound R-loops are shown as mean values ± SD from three independent experiments. Statistical evaluation was performed by ANOVA test. **** P < .0001. ( E ) The TRF2–BLM interaction enhances telomere R-loop unwinding. The effect of TRF2–RAP1 on the ability of WT and mutant BLM (3A or P690L) to unwind telomere R-loops was tested as in Fig. . 32 P-labeled TERRA and R-loops were loaded as size markers (lanes 1 and 2) and resolved by native-PAGE. ( F ) Quantification of the percentages of unwound R-loops in panel (E) as mean ± SD from three independent experiments. Statistical evaluation was performed by ANOVA test. ns: non-significant ( P = .98); **** P < .0001.

Article Snippet: The deproteinized reaction mixtures by SDS and proteinase K were passed through Micro Bio-Spin 6 Column (Bio-Rad), equilibrated with buffer B. TRF2–RAP1 (50 nM) was pre-incubated with the D/R-loop substrate (2.5 nM) on ice for 10 min. Then BLM (20–80 nM) was added and incubated at 37°C for 20 min.

Techniques: Generated, Labeling, Incubation, Polyacrylamide Gel Electrophoresis, Clear Native PAGE, Mutagenesis

BLM preferentially releases TERRA over ssDNA from telomere D/R-loops. ( A ) Schematic of the assay used to measure how TRF2–RAP1 promotes BLM-mediated unwinding of RAD51/ssDNA and RAD51AP1/TERRA-generated telomeric D/R-loops. Telomere D/R-loops were generated by incubating RAD51 with IRDye-700-labeled telomere ssDNA (red), RAD51AP1 with IRDye-800-labeled TERRA (green), and telomere plasmids together as described in Fig. . Native plasmid-sized telomere D/R-loops were obtained after deproteinization and column purification. BLM with or without TRF2–RAP1 was then incubated with these D/R-loops, and ssDNA, TERRA release, or D/R-loop unwinding was analyzed by 1% agarose gels. ( B ) BLM preferentially releases TERRA over ssDNA from telomere D/R-loop. BLM (20, 40, 80 nM) was tested for its ability to unwind telomere D/R-loops or TRF2–RAP1-bound D/R-loops. ssDNA, TERRA release, or D/R-loop unwinding was analyzed by 1% agarose gels. The unwinding of telomere D/R-loops by BLM was enhanced by TRF2–RAP1. ( C ) Quantification of the amount of D- and R-loops relative to the negative control (no proteins, lane 1). Data were plotted as mean ± SD from three independent experiments. Statistical evaluation was performed by ANOVA test. * P = .02282; ** P = .001278; *** P = .0007284; **** P < .0001. ( D ) The effects of TRF2–RAP1 on WT BLM, the helicase-dead BLM K695R or BLM mutants on D/R-loop unwinding were tested as in panel (B). In contrast to WT BLM, TRF2–RAP1 cannot enhance BLM ’s ability to unwind telomere D/R-loops. D/R-loop unwinding was analyzed by 1% agarose gels. ( E ) Quantification of the relative amounts of D-loops or R-loops to the control without proteins (lane 1) is shown as mean ± SD from three independent experiments. ANOVA test was used to evaluate statistical differences. ns: non-significant ( P = .15; .4147; .8026); ** P = .001193; *** P = .000158.

Journal: Nucleic Acids Research

Article Title: TRF2–RAP1 inhibits homology-directed repair of telomeres by promoting BLM-mediated removal of telomere R-loops

doi: 10.1093/nar/gkag272

Figure Lengend Snippet: BLM preferentially releases TERRA over ssDNA from telomere D/R-loops. ( A ) Schematic of the assay used to measure how TRF2–RAP1 promotes BLM-mediated unwinding of RAD51/ssDNA and RAD51AP1/TERRA-generated telomeric D/R-loops. Telomere D/R-loops were generated by incubating RAD51 with IRDye-700-labeled telomere ssDNA (red), RAD51AP1 with IRDye-800-labeled TERRA (green), and telomere plasmids together as described in Fig. . Native plasmid-sized telomere D/R-loops were obtained after deproteinization and column purification. BLM with or without TRF2–RAP1 was then incubated with these D/R-loops, and ssDNA, TERRA release, or D/R-loop unwinding was analyzed by 1% agarose gels. ( B ) BLM preferentially releases TERRA over ssDNA from telomere D/R-loop. BLM (20, 40, 80 nM) was tested for its ability to unwind telomere D/R-loops or TRF2–RAP1-bound D/R-loops. ssDNA, TERRA release, or D/R-loop unwinding was analyzed by 1% agarose gels. The unwinding of telomere D/R-loops by BLM was enhanced by TRF2–RAP1. ( C ) Quantification of the amount of D- and R-loops relative to the negative control (no proteins, lane 1). Data were plotted as mean ± SD from three independent experiments. Statistical evaluation was performed by ANOVA test. * P = .02282; ** P = .001278; *** P = .0007284; **** P < .0001. ( D ) The effects of TRF2–RAP1 on WT BLM, the helicase-dead BLM K695R or BLM mutants on D/R-loop unwinding were tested as in panel (B). In contrast to WT BLM, TRF2–RAP1 cannot enhance BLM ’s ability to unwind telomere D/R-loops. D/R-loop unwinding was analyzed by 1% agarose gels. ( E ) Quantification of the relative amounts of D-loops or R-loops to the control without proteins (lane 1) is shown as mean ± SD from three independent experiments. ANOVA test was used to evaluate statistical differences. ns: non-significant ( P = .15; .4147; .8026); ** P = .001193; *** P = .000158.

Article Snippet: The deproteinized reaction mixtures by SDS and proteinase K were passed through Micro Bio-Spin 6 Column (Bio-Rad), equilibrated with buffer B. TRF2–RAP1 (50 nM) was pre-incubated with the D/R-loop substrate (2.5 nM) on ice for 10 min. Then BLM (20–80 nM) was added and incubated at 37°C for 20 min.

Techniques: Generated, Labeling, Plasmid Preparation, Purification, Incubation, Negative Control, Control

TRF2–RAP1–BLM is required to resolve telomere R-loops in U2OS cells. ( A ) U2OS cells expressing TRF2 ΔB, L288R were treated with shControl, shBLM, or shTRF2. Immunofluorescence-FISH analysis of cells containing UTs (PNA telomere probe, red) co-localized with R-loops (S9.6 antibody, green) and DAPI-stained nuclei (blue). White arrow: co-localization of R-loops on UTs. U2OS cells expressing shBLM-resistant WT BLM cDNA and indicated BLM mutants were treated with shBLM, shTRF2, and TRF2 ΔB, L288R . IF-FISH analysis was performed to detect UT/R-loop co-localization. White arrow: co-localization of R-loops on UTs. ( C ) Quantification of data from Fig. and , showing the number of UT/R-loop colocalizations per U2OS cell. Data from three independent experiments is shown as mean ± SEM from minimum 200 nuclei per experiment. Statistical evaluation was performed by one-way ANOVA test. ns: non-significant ( P > .9999); ** P = .0032; .0035; .0062; .0092; .0052; **** P < .0001. ( D ) Model showing that TRF2–RAP1 inhibits telomere HDR by promoting BLM-mediated telomere R-loop removal. RAD51AP1 and TERRA-dependent R-loops promote RAD51-mediated telomere D-loop formation. The TRF2–RAP1 complex and TRF2–BLM interaction are required to promote BLM helicase-mediated unwinding of telomere R-loops and then D-loops. The RAP1–TRF2–BLM complex represses HDR on telomeres by removing R-loops to inhibit telomere D-loop formation.

Journal: Nucleic Acids Research

Article Title: TRF2–RAP1 inhibits homology-directed repair of telomeres by promoting BLM-mediated removal of telomere R-loops

doi: 10.1093/nar/gkag272

Figure Lengend Snippet: TRF2–RAP1–BLM is required to resolve telomere R-loops in U2OS cells. ( A ) U2OS cells expressing TRF2 ΔB, L288R were treated with shControl, shBLM, or shTRF2. Immunofluorescence-FISH analysis of cells containing UTs (PNA telomere probe, red) co-localized with R-loops (S9.6 antibody, green) and DAPI-stained nuclei (blue). White arrow: co-localization of R-loops on UTs. U2OS cells expressing shBLM-resistant WT BLM cDNA and indicated BLM mutants were treated with shBLM, shTRF2, and TRF2 ΔB, L288R . IF-FISH analysis was performed to detect UT/R-loop co-localization. White arrow: co-localization of R-loops on UTs. ( C ) Quantification of data from Fig. and , showing the number of UT/R-loop colocalizations per U2OS cell. Data from three independent experiments is shown as mean ± SEM from minimum 200 nuclei per experiment. Statistical evaluation was performed by one-way ANOVA test. ns: non-significant ( P > .9999); ** P = .0032; .0035; .0062; .0092; .0052; **** P < .0001. ( D ) Model showing that TRF2–RAP1 inhibits telomere HDR by promoting BLM-mediated telomere R-loop removal. RAD51AP1 and TERRA-dependent R-loops promote RAD51-mediated telomere D-loop formation. The TRF2–RAP1 complex and TRF2–BLM interaction are required to promote BLM helicase-mediated unwinding of telomere R-loops and then D-loops. The RAP1–TRF2–BLM complex represses HDR on telomeres by removing R-loops to inhibit telomere D-loop formation.

Article Snippet: The deproteinized reaction mixtures by SDS and proteinase K were passed through Micro Bio-Spin 6 Column (Bio-Rad), equilibrated with buffer B. TRF2–RAP1 (50 nM) was pre-incubated with the D/R-loop substrate (2.5 nM) on ice for 10 min. Then BLM (20–80 nM) was added and incubated at 37°C for 20 min.

Techniques: Expressing, Immunofluorescence, Staining